Practicing Personalized Evidence-Based Medicine in CLL through Risk Stratification and Patient Education
|Practicing Personalized Evidence-Based Medicine in CLL through Risk Stratification and Patient Education|
CME, CPE, CNE
Beth Faiman, PhD, CNP; Heidi D. Finnes, PharmD, BCOP; Jeffrey Jones, MD
|Release Date: January 17, 2017|
Expiration Date: January 17, 2018
In this activity, our multidisciplinary team of experts will present key risk-stratification strategies and associated treatment pathways for patients with CLL. Aspects of care that are critical to improved patient outcomes from an interdisciplinary point of view will be discussed, including concomitant medications and important aspects of patient monitoring. In addition, participants will gain an understanding of the role of shared decision-making and communication strategies to engage their patients in ongoing discussions related to their diagnosis and treatment.
As a bonus resource, we invite you to participate in the added benefits of this activity:
Provided by MediCom Worldwide, Inc.
|Begin, Earn CreditView Only, No Credit|